Ferriprox Approval History
FDA Approved: Yes (First approved October 14, 2011)
Brand name: Ferriprox
Generic name: deferiprone
Dosage form: Tablets
Company: ApoPharma Inc.
Treatment for: Hemosiderosis
Ferriprox (deferiprone) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.
Development History and FDA Approval Process for Ferriprox
|Oct 14, 2011||FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body|
|Sep 14, 2011||ApoPharma Announces FDA Advisory Committee Recommendation in Favor of Ferriprox (deferiprone) Approval|